alphaveMEDICO₹35.00

Medico Remedies Limited

₹ CrorePeersMEDICAMEQ HALEOSLABS AAREYDRUGS NECLIFE ALBERTDAVD VALIANTLAB NATCAPSUQ ZIMLABMcap ₹0.1 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	20.3	20.5	20.1	20.1
+ Capital Work-in-Progress	1.1	1.1	2.6	2.6
+ Investment Property	0.0	—	0.3	0.3
+ Other Intangibles	0.1	0.1	0.0	0.0
+ Non-current Investments	0.2	0.2	0.0	0.0
+ Other Non-current Financial Assets	0.6	0.9	0.8	0.8
Non-current Financial Assets	0.8	1.1	0.9	0.9
+ Deferred Tax Assets	—	0.1	0.4	0.4
+ Other Non-current Assets	0.2	0.2	0.2	0.2
Total Non-current Assets	22.4	22.9	24.5	24.5
Current Assets
+ Inventories	16.3	26.7	30.0	30.0
+ Current Investments	1.4	1.5	1.8	1.8
+ Trade Receivables	49.6	57.2	82.0	82.0
+ Cash & Cash Equivalents	0.2	1.1	1.9	1.9
+ Short-term Loans	0.2	0.2	0.3	0.3
+ Other Current Financial Assets	6.1	10.0	0.0	0.0
Current Financial Assets	57.4	69.9	86.0	86.0
+ Other Current Assets	—	—	12.9	12.9
Total Current Assets	73.8	96.7	128.9	128.9
Total Assets	96.2	119.6	153.4	153.4
Equity
+ Equity Share Capital	16.6	16.6	16.6	16.6
+ Other Equity / Reserves	35.8	45.7	58.9	58.9
Equity — Owners of Parent	52.4	62.3	75.5	75.5
Total Equity	52.4	62.3	75.5	75.5
Liabilities
+ Borrowings — Non-current	0.9	0.4	0.3	0.3
Non-current Financial Liabilities	0.9	0.4	0.3	0.3
+ Deferred Tax Liabilities	0.1	—	—	—
Non-current Liabilities	1.0	0.4	0.3	0.3
+ Borrowings — Current	7.2	14.3	18.5	18.5
+ Trade Payables	31.5	34.7	49.3	49.3
+ Other Current Financial Liab	—	—	0.4	0.4
Current Financial Liabilities	38.7	49.0	68.2	68.2
+ Current Tax Liabilities	1.1	1.7	2.8	2.8
+ Other Current Liabilities	3.0	6.2	6.6	6.6
Current Liabilities	42.8	57.0	77.6	77.6
Total Liabilities	43.8	57.3	77.9	77.9
Total Equity & Liabilities	96.2	119.6	153.4	153.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	3.2	2.2	2.2
+ Dues to Other Creditors — Current	—	31.5	47.1	47.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.